-
Editorial
November 30, 2023
- Summarizing the Intentions and Outcomes of JUO 2023 Issue 3
- Cheol Kwak
- J Urol Oncol. 2023;21(3):181-182.
Editorial
November 30, 2023
Invited Review
November 30, 2023
Topic Article
November 30, 2023
Invited Review
November 30, 2023
Invited Review
November 30, 2023
Invited Review
November 30, 2023
Topic Article
November 30, 2023
Original Article
November 30, 2023
Topic Article
November 30, 2023
Topic Article
November 30, 2023
Original Article
November 30, 2023
Erratum: Addition of the second author
November 30, 2023
This archive contains links to the full-text of all issues.
![]() |
4,313 | Utility of Next-Generation Sequencing for Deciphering Intratumor Heterogeneity in Prostate Cancer |
4,173 | Understanding Cancer Pain and Controlling Pain: Focusing on Patients With Metastatic Urologic Cancer |
4,009 | The Development of Antibody-Drug Conjugates for Urothelial Carcinoma Treatment |
3,980 | Expert Group Consensus Opinion on Prostate Cancer Diagnosis and Management in India: Part 2 of 2 |
3,941 | Laparoscopic Radical Cystectomy With Intracorporeal Orthotopic Neobladder Reconstruction: An Initial Experience of Modified Studer Reconstruction Techniques |
Cited By 2 |
Complex Epidemiology of Prostate Cancer in Asian Countries |
Cited By 2 |
Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades |
Cited By 2 |
Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use |
Cited By 1 |
Understanding Cancer Pain and Controlling Pain: Focusing on Patients With Metastatic Urologic Cancer |
Cited By 1 |
The Effects of Recombinant Bacillus Calmette-Guérin Resistant to Antimicrobial Peptides on Orthotopic Bladder Cancer Mouse Model |